A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment
|ClinicalTrials.gov Identifier: NCT01939860|
Recruitment Status : Completed
First Posted : September 11, 2013
Last Update Posted : December 5, 2017
Hypertension is a major health problem, however its control is unsatisfactory. One of the reasons for such a high prevalence of this disease includes poor patient compliance to treatment. Approximately 30 % of newly diagnosed hypertensive patients stop taking their blood pressure medication by six months and 50% by 12 months.
The UK government is keen to encourage community pharmacists to play an active role in participation of services that can improve patient adherence to their medications. The New Medicines Service (NMS) and targeted Medicines Use Reviews (MUR) are established services which fund community pharmacists to review and explain medicine use to patients, with hypertension a common condition for which advice is given within these schemes. Within these schemes, advice is verbal and unstructured, with no specific written information provided on drugs or the disease being treated.
This study aims to determine whether structured information provided to participants verbally and in writing by community pharmacists about blood pressure and current medicine(s) within NMS and targeted MURs will be retained and will be associated with improved hypertension control. Participants will be recruited from people eligible for NMS and MURs and attending community pharmacies.
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Other: Written and verbal patient education on hypertension and its treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||56 participants|
|Intervention Model:||Parallel Assignment|
|Actual Study Start Date :||January 2014|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
No Intervention: Usual pharmacy care
Participants will not receive any structured written education on hypertension and its treatment
Experimental: usual pharmacy care plus structured information
Participants will be provided with validated verbal and written information on hypertension and its treatment, including information about class (es) of anti-hypertensive medication(s) used by each patient, and their common side-effects. The written material will be based on validated patient information leaflets from the British Heart Foundation and the Blood Pressure Association.
Other: Written and verbal patient education on hypertension and its treatment
- Changes in systolic or diastolic blood pressure [ Time Frame: 1 year (trial would be stopped at 26 weeks if it is not possible to recruit any further participants ]Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors
- change in the knowledge of hypertension [ Time Frame: one year(trial would be stopped at 26 weeks if it is not possible to recruit any further participants) ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01939860
|J P Goes chemist|
|Coventry, United Kingdom|